Barbara Gosden
About
In The Last Decade
Barbara Gosden
15 papers receiving 519 citations
Peers
Comparison fields: 5 of 80
- Genetics 300
- Molecular Biology 119
- Health, Toxicology and Mutagenesis 69
- Pharmacology 61
- Oncology 57
Countries citing papers authored by Barbara Gosden
This map shows the geographic impact of Barbara Gosden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Gosden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Gosden more than expected).
Fields of papers citing papers by Barbara Gosden
This network shows the impact of papers produced by Barbara Gosden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Gosden. The network helps show where Barbara Gosden may publish in the future.
Co-authorship network of co-authors of Barbara Gosden
This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Gosden. A scholar is included among the top collaborators of Barbara Gosden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Gosden. Barbara Gosden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 19 | |
| 2 | 7 | |
| 3 | 10 | |
| 4 | 11 | |
| 5 | CHANGES IN IMIPRAMINE AND ALPHA-2-ADRENOCEPTOR BINDING-SITES IN THE EARLY PUERPERIUM | 1 |
| 6 | 107 | |
| 7 | 64 | |
| 8 | 15 | |
| 9 | 55 | |
| 10 | 26 | |
| 11 | 6 | |
| 12 | Determination and pharmacology of a new hydroxylated metabolite of tamoxifen observed in patient sera during therapy for advanced breast cancer. | 78 |
| 13 | 50 | |
| 14 | 22 | |
| 15 | 78 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.